Verge Genomics is a Biotech company based in San Francisco, California. It has raised $180M in total funding. Latest round: Seed.
Verge Genomics funding overview
Verge Genomics is a Biotech company based in San Francisco, California. Verge Genomics has raised $180M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Seed. Investors on record include BlackRock, Eli Lilly, Merck GHI, Threshold, Y Combinator. 5 distinct backers are named across the disclosed rounds.
Verge Genomics at a glance
Total raised
$180M
Latest round
Seed
Industry
Biotech
Headquarters
San Francisco, California
Notable investors
BlackRock, Eli Lilly, Merck GHI, Threshold, Y Combinator
Frequently asked about Verge Genomics funding
How much has Verge Genomics raised?
Verge Genomics has raised $180M in total disclosed funding across the rounds on record.
Who has invested in Verge Genomics?
BlackRock, Eli Lilly, Merck GHI, Threshold, Y Combinator are named among the investors backing Verge Genomics.
What was the latest Verge Genomics funding round?
The most recent disclosed round is a Seed.
Where is Verge Genomics based?
Verge Genomics is based in San Francisco, California.
What sector does Verge Genomics operate in?
Verge Genomics is tracked under Biotech from San Francisco, California, with $180M in disclosed funding.
Verge Genomics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in San Francisco below to benchmark round size and investor mix.
